Fennec pharmaceuticals inc FENC.US Overview Analysis
FENC AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
FENC Current Performance
5.38%
Fennec pharmaceuticals inc
4.57%
Avg of Sector
3.26%
S&P500
Top 10 High Relevance to FENC
- MBX Mbx biosciences incValue -Trend 3Swing Trading 5Whale Interest 2Dividend 1See more
FENC Profile
Fennec Pharmaceuticals Inc. The Group's principal activities are to develop therapeutic drugs based upon proprietary cell adhesion technology platform. The Group focuses on the development of transdermal drug delivery methods. The drugs are used in the treatment of cancer, also applied in cases of neural regeneration, the treatment of restenosis, cancer metasis and other medical disorders where treatment includes compounds that suppress cadherin activity.